This inventor holds 1 USPTO granted patent. Top assignee: University of Kansas. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Jack Douglas Weiner: Innovator in Pharmaceutical Compounds
Introduction
Jack Douglas Weiner is a notable inventor based in Overland Park, Kansas. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on compounds that enhance the efficacy of anti-CD20 monoclonal antibodies.
Latest Patents
Weiner holds a patent for Kifunensine derivatives, which relates to compounds according to Formula I or a pharmaceutically acceptable salt and/or solvate thereof. The patent highlights the significant upregulation of CD20 by the inhibition of α-mannosidase enzymes, which potentiates the activity of anti-CD20 monoclonal antibodies. This technology is particularly important as it sensitizes cell lines that are resistant to the action of these antibodies. He has 1 patent to his name.
Career Highlights
Weiner is affiliated with the University of Kansas, where he continues to engage in research and development of pharmaceutical innovations. His work has implications for improving treatments for conditions that require the use of monoclonal antibodies.
Collaborations
Among his notable coworkers are Patrick Andrew Ross and Suresh Eknath Kurhade, who have collaborated with him on various research projects.
Conclusion
Jack Douglas Weiner's contributions to pharmaceutical compounds demonstrate his commitment to advancing medical science and improving therapeutic options. His innovative work continues to impact the field positively.